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characteristics. ConClusions: Based on this analysis, substantial proportions of 
patients in Class II and III were not hospitalized, possibly reflecting a trend toward 
treatment of moderate ABSSSI patients in the ambulatory setting. Switching appro-
priate patients from inpatient to OPAT setting could potentially save the health 
system approximately $6,000-7,000/patient.
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objeCtives: To assess outcomes of clostridium difficile infection (CDI) and the 
association of expenditures and CDI in pediatric solid organ transplant (SOT) recipi-
ents. Methods: Data from the 2000, 2003, 2006, and 2009 Kids’ Inpatient Database 
(KID) files were used to identify events with SOT- related ICD-9-CM diagnosis codes. 
The data were evaluated using logistic regressions and log-linked gamma regres-
sions. Results: The total number of pediatric SOT hospital events was 48,286. 
The overall prevalence of CDI for pediatric SOT hospitalizations was 1.76%. For 
SOT hospitalizations with CDI, inpatient mortality was 1.63%; the prevalence of 
transplant failure or rejection events was 27.71%; the prevalence of a colectomy 
was 4.86%. The median LOS was seven days; the median charge for each hospitali-
zation was $48,409; and the median cost for each hospitalization was $17,412. The 
results showed that CDI was not significantly associated with inpatient mortality 
or transplant failure/ rejection in pediatric SOT hospitalizations, but the power 
to detect differences was low. SOT patients with CDI were 2.6 times more likely 
to have a colectomy than SOT patient without CDI (OR= 2.62, 95% CI= [1.63, 4.22], 
p< 0.001). The mean LOS for a SOT admission with CDI was approximately 2 times 
the mean LOS for a SOT admission without CDI (coefficient= 1.93, 95% CI= [1.68, 
2.21], p< 0.001). The mean charges and the mean costs for a SOT admission with 
CDI was approximately 2 times that for a SOT admission without CDI (charges: 
coefficient= 2.01, 95% CI= [1.63, 2.46], p< 0.001; costs: coefficient= 1.96, 95% CI= [1.50, 
2.58], p< 0.001). ConClusions: CDI diagnoses were not significantly associated 
with higher inpatient mortality or transplant failure/ rejection for pediatric SOT 
hospitalizations. But CDI was significantly associated with a higher prevalence of 
a colectomy, longer hospital LOS, higher charges, and higher costs.
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objeCtives: Social media (SM) is increasingly being used as a data resource in 
published scientific literature to study disease burden and perceptions of patients 
and caregivers. However, the feasibility, ethics and legality of using SM in outcomes 
research remain unclear. We aimed to explore these issues in the context of adult 
vaccination. Methods: We searched the internet using different search engines 
and browsers to identify SM sites with content relevant to adult vaccination. We 
developed a decision-matrix based on weighted characteristics to determine which 
sites are most useful for in-depth data analysis. Thirty-five SM sites were scored for 
popularity, amount and type of content relevant to vaccination, data use restric-
tions, and feasibility of accessing the data. Results: SM sites with relevant content 
included general sites such as Facebook, Twitter, and YouTube; and health-specific 
sites such as HealthUnlocked, PatientsLikeMe, and SmartPatients. Although sev-
enteen sites facilitated access to their public-facing content via interfaces such as 
application programming interfaces (APIs), nine sites had limitations to the use of 
public content for non-personal reasons. Two sites did not support the download 
and storing of site content for in-depth analysis and audit, while data from most 
sites could only be downloaded manually or by automatic ‘scraping’. All selected 
sites facilitated responses to an initial post, but only a minority had examples 
of multi-user conversations or discussions about vaccination in adults. The sites 
with the most potential for in-depth data analysis were Google+, Twitter, YouTube, 
Yahoo Answers, and Facebook. ConClusions: Contrary to popular opinion, data 
that is available for all to browse and disseminate rapidly and globally is not always 
legally and practically accessible for research. Clarification of the issues around 
the use of SM for health research is needed to establish best practice guidance for 
this rich resource.
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objeCtives: Emergence of resistance towards almost all broad spectrum antibiot-
ics is rapidly increasing and one of the main causes is irrational and inappropriate 
prescription of carbapenems. Hence the current study was carried out to assess 
the prescribing pattern of carbapenems in medical intensive care unit of a private 
tertiary care hospital. Methods: A retrospective observational study was car-
ried out in patients prescribed with carbapenems in MICU for a period of 1 year. 
Only patients having stay of more than 24 hours were included in study. Results: 
Out of total 138 patients, 127 patients were included in the study as per protocol. 
Average age of patient was found to be 55.2 ± 1.684 years. Mean Acute Physiology 
and Chronic Health Evaluation (APACHE) – IV Score was 72.63 which show critical 
condition of the admitted patients. Fifty four percent patients were with severe 
sepsis and 32% were in septic shock. In 86 patients carbapenems were prescribed 
at first day of admission in ICU. Most of the prescribed drug was meropenem fol-
lowed by doripenem and imipenem. Mostly prescribed concomitant antimicrobials 
were glycopeptides, antifungals and metronidazole. Prescription and switching of 
antimicrobials was according to culture sensitivity reports in 97% cases. Survival 
outcome was 64%. ConClusions: Prescription of broad spectrum antimicrobials 
objeCtives: US Health Reform is stimulating new models of care, such as pharma-
cist vaccination programs. While pharmacist vaccination holds promise in improv-
ing access to this important preventive modality, evidence on these programs is still 
emerging. The objective of this research was to conduct a systematic review of pub-
lished evidence on pharmacist immunization programs for two common diseases-- 
influenza and pneumococcal disease. Methods: Ten PubMed literature searches 
were performed using the keywords pharmacist, vaccination, program, policy, cost, 
and education. Inclusion criteria: pharmacist administration of immunizations and 
published between 2000 and 2013. Exclusion criteria: student pharmacists used 
as immunizers and research was non-US. Results: 102 articles were identified. 
Of these, 52 met inclusion criteria; 30 (57.7%) were primary research, 22 (42.3%) 
were secondary research. Older adults (≥ age 65) were the most common target 
for pharmacist vaccination programs (21.2%), followed by 9.6% targeting a specific 
ethnicity, 7.7% targeting individuals with chronic conditions, and 5.8% targeting 
individuals at high risk for the disease. Patient-reported barriers to pharmacist vac-
cination included: accessibility to the pharmacist (42.3%), cost/insurance concerns 
(36.5%), lack of health care provider recommendation (19.2%), lack of awareness 
of the illness (15.4%), and fears that the vaccine will cause illness (11.5%). The lit-
erature lacked program cost and outcome data such as knowledge and vaccina-
tion rates. ConClusions: Though intuitively it would seem that pharmacists are 
highly accessible, the literature suggests that access to pharmacists is, instead, a 
barrier to vaccination, perhaps due to time limitations or physical infrastructure not 
conducive to vaccination. Cost or insufficient insurance coverage for pharmacist-
administered vaccines is also a concern. More evidence is needed on the outcomes 
of these programs in terms of improving pharmacist accessibility, vaccination rates 
and knowledge about the disease, as well as economic data to inform decision mak-
ers on their value in relation to traditional models of care.
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objeCtives: Immunization is a cost-effective strategy to reduce the impact of influ-
enza among elderly. The purpose of this study was to examine racial disparities in 
influenza vaccination in elderly after controlling for individual and higher level 
factors. Methods: The 2011 Behavioral Risk Factor Surveillance System Selected 
Metropolitan/Metropolitan Area Risk Trends (BRFSS SMART) dataset was used for 
this study. Study population consisted of individuals aged 65 years or above and 
those who responsded as either yes or no about having received seasonal flu shot/
spray during the last one year. Race, age, gender, education level, employment sta-
tus, marital status, health insurance coverage and medical cost were used as level 
1 variables. United States county code and race aggregated at level 2 were used as 
level 2 variables. Two-level logistic regression analysis was used to examine racial 
disparities in influenza vaccination in elderly. Results: The study cohort consisted 
of 66,165 subjects. Of these, 41,427 (62.61%) received influenza vaccination. Mean 
age of the study sample was 75 years (74.64 ± 7.20). Most of the elderly patients 
receiving influenza vaccination were females (64.09%), Whites (87.99%), and insured 
(99.86%). Results from multilevel modeling suggested that individuals’ race (odds 
ratio:1.289, p value < .0001), and other factors like age, gender, education level, 
employment status, marital status, health insurance coverage and medical cost 
were significantly associated with influenza vaccination in elderly. Effect of race 
varied significantly across counties for influenza vaccination in elderly. Additionally, 
county-level race moderated the effect of individual race for influenza vaccination 
in elderly. ConClusions: Racial disparities exist in influenza vaccination among 
elderly even after controlling for individual and higher level factors. Individual level 
factors were better predictors of influenza vaccination in elderly than the level 2 
factors. However, it is always desirable to use multilevel approach when the nature 
of the data is inherently nested.
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objeCtives: Acute bacterial skin and skin structure infections (ABSSSIs) are the 
second most common indication for antibiotic treatment. Eron et al. developed 
an algorithm for disease severity and appropriate treatment to optimize patient 
care and minimize costs. However, this algorithm has yet to be thoroughly vali-
dated in the real-world. The objectives of this study were to investigate the current 
ABSSSI patient population and compare the direct health care costs associated with 
inpatient versus outpatient parenteral antimicrobial therapy (OPAT) treatment, by 
patient severity level, in the US. Methods: ABSSSI patient characteristics were 
evaluated using the Premier Hospital Database. Standard data elements in hospital 
discharge files, including diagnoses and procedures categorized by International 
Classification of Diseases, Ninth Revision were used to classify patients according 
to the Eron classes I-IV. Data for this study were extracted from January to Dec 
2012. Results: There were 533,263 hospital and emergency room discharges with 
a principal diagnosis of ABSSSI included for analysis. The percentages of patients 
categorized as Eron Class I-IV were 73.47%, 20.15%, 4.75% and 1.63% respectively. 
20.35% of patients were hospitalized; 9.26%, 43.51%, 71.36% and 85.54% in Class I-IV 
respectively. The unadjusted costs associated with inpatient versus OPAT treat-
ment varied substantially by disease severity: mean costs were $5,729 inpatient vs. 
$368 OPAT for Class I, $7,651 vs. $634 for Class II, $10,339 vs. $823 for Class III, and 
$16,559 vs. $1,050 for Class IV. The cost increases for inpatient versus OPAT treat-
ment ranged from $6,303 to $7,351 for Class II and III after adjustment for baseline 
